Quarterly Transactions Made in Fulcrum Therapeutics, Inc. (FULC)
This table provides information about the institutional ownership of Fulcrum Therapeutics, Inc. (FULC). The information is specifically focused on institutions that hold shares of Fulcrum Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 7,244,774 | 7,215,644 | 14,460,418 | 2,732,175 | 1,686,708 | 4,418,883 | 10,041,535 | |
| Q4 2021 | 3,998,206 | 3,171,088 | 7,169,294 | 2,356,483 | 3,933,164 | 6,289,647 | 879,647 | |
| Q1 2022 | 2,380,683 | 4,115,833 | 6,496,516 | 2,907,513 | 1,528,045 | 4,435,558 | 2,060,958 | |
| Q2 2022 | 5,788,804 | 509,140 | 6,297,944 | 4,236,638 | 1,831,160 | 6,067,798 | 230,146 | |
| Q3 2022 | 5,505,878 | 9,634,034 | 15,139,912 | 1,527,788 | 28,500 | 1,556,288 | 13,583,624 | |
| Q4 2022 | 6,253,470 | 1,528,991 | 7,782,461 | 7,900,267 | 0 | 7,900,267 | -117,806 | |
| Q1 2023 | 11,004,801 | 7,472,330 | 18,477,131 | 1,805,126 | 0 | 1,805,126 | 16,672,005 | |
| Q2 2023 | 5,410,173 | 1,426,296 | 6,836,469 | 7,336,298 | 17,020 | 7,353,318 | -516,849 | |
| Q3 2023 | 3,311,093 | 2,657,858 | 5,968,951 | 2,259,449 | 0 | 2,259,449 | 3,709,502 | |
| Q4 2023 | 3,084,884 | 22,173,049 | 25,257,933 | 3,099,611 | 0 | 3,099,611 | 22,158,322 | |
| Q1 2024 | 3,235,501 | 3,789,776 | 7,025,277 | 6,322,093 | 0 | 6,322,093 | 703,184 | |
| Q2 2024 | 9,440,825 | 13,650,274 | 23,091,099 | 4,777,967 | 0 | 4,777,967 | 18,313,132 | |
| Q3 2024 | 4,630,824 | 13,359,624 | 17,990,448 | 10,712,064 | 94,181 | 10,806,245 | 7,184,203 | |